Stay updated on Open-Label Surufatinib in EU NET Patients Clinical Trial

Sign up to get notified when there's something new on the Open-Label Surufatinib in EU NET Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Open-Label Surufatinib in EU NET Patients Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision entry updated from v3.3.3 to v3.3.4; core study details remain unchanged.
    Difference
    0.0%
    Check dated 2026-01-15T04:41:01.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    - A consolidated Locations section was added listing study sites across Alabama, California, Georgia, New York, and Texas, with the previous state-specific location headings removed. The page revision was updated to v3.3.3.
    Difference
    0.6%
    Check dated 2025-12-24T15:16:36.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.2.0 to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-25T14:46:44.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Notice about potential government funding delays was removed. The core study information remains unchanged.
    Difference
    0.3%
    Check dated 2025-11-18T07:31:50.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Posted study results are now visible on the page, and the study record dates have been updated to include Results First Posted 2025-07-25.
    Difference
    0.4%
    Check dated 2025-10-27T21:12:56.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    The page updates to include a government funding lapse notice and a status update about operating conditions, plus a new version label (v3.2.0) while removing the old version (v3.1.0).
    Difference
    3%
    Check dated 2025-10-06T08:23:21.000Z thumbnail image

Stay in the know with updates to Open-Label Surufatinib in EU NET Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Open-Label Surufatinib in EU NET Patients Clinical Trial page.